Europe Equine Healthcare Market Size, Share, Trends, Industry Analysis Report: By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software, and Others), Indication, Activity, Distribution Channel, and Country – M

Europe Equine Healthcare Market Size, Share, Trends, Industry Analysis Report: By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software, and Others), Indication, Activity, Distribution Channel, and Country – Market Forecast, 2024–2032

The Europe equine healthcare market size is expected to reach USD 1,959.48 million by 2032, according to a new study by Polaris Market Research. The report “Europe Equine Healthcare Market Size, Share, Trends, Industry Analysis Report: By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Orthobiologics, Software, and Others), Indication, Activity, Distribution Channel, and Country – Market Forecast, 2024–2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The equine healthcare market in Europe is experiencing significant growth, driven by various factors such as the expansion of veterinary services, increasing awareness of equine health, and rising incidences of equine diseases. Higher disease prevalence leads to a stronger emphasis on preventive care, such as parasite control, vaccinations, and biosecurity measures. This drives demand for the products and services aimed at disease prevention. Thus, the high prevalence of equine diseases propels the Europe equine healthcare market growth.

The high prevalence of equine diseases in Europe, along with the rising equestrian activities, drives the equine healthcare market. Growing equestrian activities and higher disease prevalence focus a stronger emphasis on equine related services such as preventive care and others, thereby driving market. For instance in June 2020, Germany has reported an outbreak of equine infectious anaemia (EIA) affecting one equid (presumably a horse) in the federal state of Hesse in Western Germany.

Europe Equine Healthcare Market Report Highlights

• In terms of activity, the sports/racing segment accounted for the largest market share in 2023, owing to the growing popularity of equestrian sports and competitive racing across Europe.
• The recreation segment is expected to witness the highest growth during the forecast period, owing to the rise in recreational riding and leisure activities
• Based on product, the pharmaceuticals segment accounted for the largest market share in 2023, owing to the persistent demand for advanced treatments for common equine conditions such as respiratory infections and musculoskeletal issues.
• The software segment is projected to grow at a robust pace in the coming years because of the increasing integration of digital technologies in equine healthcare management.
• The UK accounted for a major market share in 2023. The market growth in the country is attributed to the growing emphasis on recreational riding and the increasing number of leisure horses. Furthermore, the increasing incidence of equine influenza, West Nile virus, and tetanus diseases among horses in the UK boosts the country's market growth.
• The market in Germany is projected to register the fastest growth during the forecast period, attributable to its well-established equestrian industry and robust healthcare infrastructure. Additionally, Germany’s advanced veterinary research institutions and high standards of care contribute to its market growth.
• Zoetis Services LLC; Arthrex Inc.; Dechra; Ceva Sante Animale; Merck & Co., Inc.; Heska Corporation; Hallmarq Veterinary Imaging; ESAOTE SPA; Vetoquinol S.A.; IDEXX Laboratories, Inc.; Elanco; Covetrus Inc.; Cargill; and Biosig Instruments Inc. are among the European market players.

Polaris Market Research has segmented the Europe equine healthcare market report on the basis of product, indication, activity, distribution channel, and country:

By Product Outlook (Revenue, USD million, 2019–2032)

• Vaccines
• Pharmaceuticals

- Parasiticides

- Anti-infectives

- Anti-inflammatory & Analgesics

- Other Pharmaceuticals

• Medicinal Feed Additives
• Orthobiologics
• Diagnostics

- Diagnostic Test Kits

- Diagnostic Equipment

• Software

- Practice Management Software

- Imaging Software

- Telehealth Software

- Other Software

• Other

By Indication Outlook (Revenue, USD million, 2019–2032)

• Musculoskeletal Disorders
• Parasitic Infections
• Equine Herpes Virus
• Equine Viral Arteritis (EVA)
• Equine Influenza
• West Nile Virus
• Tetanus
• Other

By Activity Outlook (Revenue, USD million, 2019–2032)

• Sports/Racing
• Recreation
• Other

By Distribution Channel Outlook (Revenue, USD million, 2019–2032)

• Veterinary Hospitals & Clinics
• E-commerce
• Equestrian Facilities
• Other

By Country Outlook (Revenue, USD million, 2019–2032)

• Germany
• UK
• France
• Italy
• Spain
• Switzerland
• Sweden
• Netherland
• Russia
• Rest of Europe